The guidelines state that clinicians should offer blue light cystoscopy, if available, as an adjunct to traditional white light cystoscopy (WLC) to increase tumor detection and decrease recurrence.

Non-muscle-invasive bladder cancer is labor intensive and costly to manage. Owing to long-term survival rates and life-long monitoring and treatment, it is the most expensive cancer to manage in ...

Cystoscopy and ureteroscopy are diagnostic or therapeutic procedures, usually performed by urologists, or doctors who specialize in diseases of the urinary tract. These procedures use endoscopes to ...

Cystoscopy without the aid of urinary markers is the most cost-effective strategy for detecting recurrence of non-invasive bladder cancer, according to researchers. In a study that examined five ...

A cystoscopy is a procedure that involves inserting a tool into the urethra and up into the bladder to examine these organs. The tool is a cystoscope — a thin, flexible instrument with a light and a ...

OSLO, Norway, March 24, 2025 /PRNewswire/ --Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces two abstract presentations at the 2025 European Association of Urology congress (EAU) in ...

May 13, 2011, 9:47 AM EDT / Source: GlobeNewswire ORANGEBURG, N.Y., May 13, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announced today the introduction by Stryker Corporation ...

Photocure ASA (($PHCUF)) announced an update on their ongoing clinical study. The Blue Light Cystoscopy With Cysview® Registry study, officially ...

Hexvix /Cysview and BLC are registered trademarks of Photocure ASA. Saphira is a registered trademark of KARL STORZ Endoscopy. This press release may contain product ...